|4Jan 3, 4:07 PM ET

DEPASQUALE MICHAEL W 4

4 · BIO KEY INTERNATIONAL INC · Filed Jan 3, 2025

Insider Transaction Report

Form 4
Period: 2024-12-31
DEPASQUALE MICHAEL W
DirectorPresident & CEO & Director
Transactions
  • Award

    Common Stock

    2024-12-31$1.40/sh+139$19539,519 total
Footnotes (2)
  • [F1]Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • [F2]All share amounts reflect BIO-key's 1-for-18 reverse stock split, which was effective December 21, 2023. Holdings do not include options to purchase 464 shares.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4